Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bristol-Myers Squibb to market Compass mental health outcomes system for disease management.

Executive Summary

BRISTOL-MYERS SQUIBB MARKETING COMPASS MENTAL HEALTH OUTCOMES SYSTEM to psychiatrists, managed care organizations and other health care practitioners under an agreement with King of Prussia, Penn.-based Compass Information Systems announced Feb. 12. "As part of its disease management program, Bristol-Myers Squibb will offer the Compass system to providers who treat patients with mental illness," the firm said. Bristol will have "exclusive pharmaceutical rights to distribute" the system.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027659

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel